Clinical Trial Update: Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

View source ↗

Summary

A clinical trial (NCT00184288) evaluating proton MR spectroscopy for evaluating treatment response in brain metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Lung Cancer
• Melanoma

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Neoplasm Metastasis, Lung Neoplasms | Status: WITHDRAWN